This article is part of the supplement: The evolution of anti-TNF therapy in rheumatic disease: experience, insights and advances

Highly Accessed Email this article to a friend

Advances in rheumatology: new targeted therapeutics

Paul P Tak* and Joachim R Kalden

  • * Corresponding author: Paul P Tak

Arthritis Research & Therapy 2011, 13(Suppl 1):S5 doi:10.1186/1478-6354-13-S1-S5

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.
How can I ensure that I receive Arthritis Research & Therapy's emails?